BIO and Washington Biotechnology & Biomedical Association (WBBA) commend Governor Jay Inslee for signing Bill 5935, which creates pathway for substitution of interchangeable biologic medicines. Policies outlined in said bill align with BIO's principles on biologic substitution, and BIO president and CEO Jim Greenwood specifically noted included "communication on all biologic medicines dispensed in order to maintain a consistent and complete medical record."